The neurology of AIDS

Section 1.  HIV-1 Biology and Immunology 
 1.1. HIV-1 Biology, Michael Bukrinsky and Sergey Iordanskiy 
 1.2. HIV-1 Immunology, Sabita Roy, Subhash Dhawan, Shilpa Buch, and Krishnakumar Devadas 
 1.3 Chemokines, Richard J. Miller 
 1.4 Viral and host genetic factors, Christopher Power, Jennifer A. McCombe, Shaona Acharjee, and M. John Gill 
 1.5 Genetic Susceptibilities in neuroAIDS, Sunil K. Ahuja, Srinivas Mummidi, Jason F. Okulicz, Edwina J. Wright, and Weijing He 
 Section 2. Innate and Cellular Immunity and Neurogenesis 
 2.1. Mononuclear phagocytes, Kenneth C. Williams, William Hickey, Tricia H. Burdo, and Caroline Soulas 
 2.2. Microglia, Sunhee C. Lee 
 2.3. Astrocytes, Etty N. Benveniste, Lisa N. Akhtar, and Brandi J. Baker 
 2.4. Adaptive Immunity, Howard E. Gendelman, Jessica A.L. Hutter, Larisa Poluektova, and Subhash Dhawan 
 2.5. Vaccines, R. Lee Mosley, Max V. Kuenstling, and Eric J. Benner 
 2.6. Neurogenesis, Jialin C. Zheng, James B Reinecke, Hui Peng, Yunlong Huang, and Qiang Chen 
 Section 3. Blood brain barrier and HIV CNS Entry 
 3.1. Blood brain barrier: Structure and function, William A. Banks 
 3.2. Endothelial cell biology and HIV-1 infection, Michal Toborek, Ibolya E. Andras, Cetewayo S. Rashid, Yu Zhong, and Shinsuke Nakagawa 
 3.3. Blood-brain barrier during neuroinflammation, Yuri Persidsky and Servio H. Ramirez 
 3.4. Mechanisms of viral and cell entry into the CNS, Eliseo A. Eugenin and J.W. Berman 
 3.5. Monocyte-macrophages and viral CNS entry, Georgette D. Kanmogne 
 Section 4. Cellular and Viral Neurotoxicity and Abused Drugs 
 4.1. Mononuclear phagocyte inflammation and neurotoxicity, Howard E. Gendelman, Andrea Martinez-Skinner, Ari Nowacek, and JoEllyn McMillan 
 4.2. Neurotoxicity of HIV-1 proteins, Ruth Brack-Werner, Manja Meggendorfer, Ina Rothenaigner, Bianca Tigges, and Michelle Vincendea 
 4.3. HIV-1 and Tat, Avindra Nath, Wenxue Li, Guanhan Li, and Joseph Steiner 
 4.4. HIV-1 gp120, Stuart A. Lipton, Shu-ichi Okamoto, Marcus Kaul, Ian Paul Everall, and Eliezer Masliah 
 4.5. HIV-1 and cannabinoids, Guy A. Cabral and Erinn S. Raborn 
 4.6. HIV-1 and METH, Howard S. Fox 
 4.7. HIV-1 and Opioids, Toby K. Eisenstein, Jessica Breslow, Changcheng Song, Mathew J. Finley, William D. Cornwell, Sumedha Chugh, Joseph J. Meissler, and Thomas J. Rogers 
 4.8. HIV-1 and Cocaine, Shilpa J. Buch, Honghong Yao, and Sabita Roy 
 Section 5. Animal models 
 5.1. SIV, Janice E. Clements, M. Christine Zink, Joseph L. Mankowski, David R. Graham, and Lucio Gama 
 5.2. FIV, Rick B. Meeker 
 5.3. CAEV, Valgerdur Andresdottir, Sigurbjorg Torsteinsdottir, and Gudmundur Georgsson 
 5.4. Transgenics, Sulie L. Chang and Marley D. Kass 
 5.5. Immunodeficient mice, Larisa Poluektova 
 5.6. SIV and opiates, Shilpa J. Buch, Shannon Callen, Paul Cheney, and Anil Kumar 
 5.7. SIV and FIV and peripheral neuropathy, Joseph L. Mankowski, Victoria A. Laast, Gigi Ebenezer, and Justin C. McArthur 
 5.8. Animal models and bioimaging, R. Gilberto Gonzalez, Eva-Maria Ratai, and Margaret R. Lentz 
 Section 6. Personal Perspectives in Living with HIV/AIDS 
 6.1. Darren Kane 
 6.2. Eric Glare 
 6.3. James May 
 6.4. Karen 
 6.5. Susan Paxton 
 Section 7. Clinical and Pathologic Manifestations of Disease 
 7.1. Prospective on HIV CNS Infections, Richard W. Price 
 7.2. HAND, Igor Grant and Ned Sacktor 
 7.3. Early Manifestations of CNS Disease, Serena S. Spudich 
 7.4. HIV-1 Neuropathology, Benjamin B. Gelman and David J. Moore 
 7.5. Peripheral Neuropathy, David M. Simpson, Kathryn J. Elliott, and Justin McArthur 
 7.6. Spinal Cord Disease, Christina M. Marra 
 7.7. Myopathy, Susan Morgello, Jessica Robinson-Papp, Kenneth A. Fox, and David M. Simpson 
 7.8. Aging, Christian L. Achim and Virawudh Soontornniyomkij 
 7.9. Addiction, R. Douglas Bruce 
 Chapter 8. Pathogenesis of Co-Morbid Conditions 
 8.1. NeuroAIDS as an Inflammatory Disorder, Dennis L. Kolson, Denise R. Cooka, Stephanie A. Crossa, and Samantha S. Soldana 
 8.2. Neuronal Injury, White Matter Disease, and Neurotrophic Factors, Dianne Langford, Eliezer Masliah, and Ian Paul Everall 
 8.3. Pathobiology of HIV-related neuropathies, BJ Brew and NWS Davies 
 8.4. CNS Co-morbidities, Georgette D. Kanmogne and David B. Clifford 
 8.5. Opportunistic Infections, Joseph R. Berger and Bruce A. Cohen 
 8.6. PML, Eugene O. Major and Maria Chiara G. Monaco 
 8.7. Neoplasms, Alexis Demopoulos and Lauren Abrey 
 8.8. Hepatitis C, Wenzhe Ho and Li Ye 
 8.9. Psychiatric Co-Morbidities, Ian Paul Everall and Timothy B. Nguyen 
 Chapter 9. Diagnostics and Biomarkers 
 9.1. Brain Imaging, Linda Chang, Ute Feger, and Thomas Ernst, Ph.D. 
 9.2. MRI, Terry L. Jernigan, Sarah L. Archibald, and Christine Fennema-Notestine 
 9.3. Psychological Evaluations, Steven Paul Woods, Jordan Elizabeth Cattie, and Igor Grant 
 9.4. Viral and Cellular Biomarkers During Antiretroviral Therapy, Scott L. Letendre 
 9.5. Viral Dynamics, Ronald J. Ellis and Davey M. Smith 
 9.6. Viral Clades, Avindra Nath and Wenxue Li 
 9.7. Proteomics and Biomarkers, Pawel Ciborowski, Gwenael Pottiez, and Jayme Wiederin 
 Chapter 10. Children and Adolescents 
 10.1. Clinical and Pathological Features of HIV-1 Encephalopathy in Children and Adolescents, Mark Mintz, Leroy Sharer, and Lucy Civitello 
 10.2. Infants, Children and Adolescents Nervous System Disease in the era of combination antiretroviral therapy, Annelies Van Rie and Anna Dow 
 10.3. Psychosocial Aspects of Neurologic Impairment in Children with AIDS, Lori Wiener and Claude Mellins 
 10.4. Growing up with HIV Disease, Lynnae Schwartz, Leslie K. Serchuck, and Shirley F. Delair 
 Chapter 11. Antiretroviral and Adjunctive Therapies 
 11.1. Current Concepts in the Treatment of HIV Infection with Focus on Brain Disease, Susan Swindells and Uriel Sandkovsky 
 11.2. Pharmacology of Antiretroviral Therapies, J. Allen McCutchan, Scott Letendre, Ronald J. Ellis, Brookie Best, and Edmund Capparelli 
 11.3. Treatment of Opportunistic Infections Associated With Human Immunodeficiency Virus Infection, David B. Clifford 
 11.4. Nanoformulated Medicines, Howard E. Gendelman, Upal Roy, Shantanu Balkundi, and JoEllyn McMillan 
 11.5. Antiretroviral nanotherapies, Madhavan P.N. Nair and Zainulabedin M. Saiyed 
 11.6.  Adjunctive Medicines, Harris A. Gelbard and Stuart A. Lipton 
 Chapter 12. Psychiatry and Psychobiology 
 12.1. Psychiatric Disorders, J. Hampton Atkinson, Nichole A. Duarte, and Glenn Treisman 
 12.2. Neuropsychiatry of Substance Abuse, Eileen M. Martin-Thomas, Andy Levine, and Raul Gonzalez 
 12.3. Psychobiology of Risk Behavior, David G. Ostrow 
 12.4. Everyday Impact of HIV-Associated Neurocognitive Disorders, Thomas D. Marcotte, J. Cobb Scott, Charles H. Hinkin, and Robert K. Heaton 
 12.5. Facing Legal and Ethical Challenges in the Treatment of AIDS, Glenn J. Treisman and Warren B. Treisman 
 12.6. Neuropsychological Testing, Kevin R. Robertson, Kevin J. Liner, Michelle Ro, and Robert K. Heaton 
 12.7. The impact of HIV subtype, cultural, and sociodemographic factors on HIV-1 infection and associated neuropathogenesis in Africa, Adelina Holguin, Damien C. Tully, and Charles Wood